These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16937460

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG, Sandborn WJ.
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [Abstract] [Full Text] [Related]

  • 23. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW, Sandborn WJ.
    Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
    [No Abstract] [Full Text] [Related]

  • 24. Update on the management of Crohn's disease.
    Buchner AM, Blonski W, Lichtenstein GR.
    Curr Gastroenterol Rep; 2011 Oct; 13(5):465-74. PubMed ID: 21792543
    [Abstract] [Full Text] [Related]

  • 25. [Drug therapy of Crohn disease].
    Niemelä S.
    Duodecim; 2001 Oct; 117(8):807-14. PubMed ID: 12116446
    [No Abstract] [Full Text] [Related]

  • 26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [Abstract] [Full Text] [Related]

  • 27. Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.
    Sandborn WJ, Feagan BG.
    Aliment Pharmacol Ther; 2003 Aug 01; 18(3):263-77. PubMed ID: 12895211
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Medical management of Crohn's disease.
    Cottone M, Renna S, Orlando A, Mocciaro F.
    Expert Opin Pharmacother; 2011 Nov 01; 12(16):2505-25. PubMed ID: 21988215
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB.
    J Crohns Colitis; 2012 Jul 01; 6(6):637-46. PubMed ID: 22398096
    [Abstract] [Full Text] [Related]

  • 33. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Drug treatment of Crohn's disease].
    van Deventer SJ, Tytgat GN.
    Ned Tijdschr Geneeskd; 1998 May 23; 142(21):1191-5. PubMed ID: 9627451
    [Abstract] [Full Text] [Related]

  • 36. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
    Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP, European Crohn's and Colitis Organisation (ECCO).
    J Crohns Colitis; 2010 Feb 23; 4(1):28-62. PubMed ID: 21122489
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.